Introduction Since 2007, the Standing Committee on Vaccination (STIKO) has recommended prophylactic vaccination to prevent human papillomavirus (HPV) infection. Possible therapeutic benefits are discussed. In this study, the effect of vaccination on the course of recurrent respiratory papillomatosis (RRP) is examined.
No takes yet. Share an insight, caveat, or question.
Sieg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: